4-(4-tert-butylphenoxy)piperidine;1-(4-tert-butylphenyl)imidazole;1-[(4-tert-butylphenyl)methyl]-4-methylpiperazine;4-[(3-tert-butylphenyl)methyl]morpholine;1-(4-tert-butylphenyl)-4-methylpiperazine;4-(4-tert-butylphenyl)morpholine;1-(4-tert-butylphenyl)piperazine;2-[4-(4-tert-butylphenyl)piperazin-1-yl]ethanol;1-(4-tert-butylphenyl)piperidine;1-(4-tert-butylphenyl)pyrazole;1-(5-tert-butyl-2-pyridinyl)piperazine

C159H241N19O4 — CID 159042031

IUPAC4-(4-tert-butylphenoxy)piperidine;1-(4-tert-butylphenyl)imidazole;1-[(4-tert-butylphenyl)methyl]-4-methylpiperazine;4-[(3-tert-butylphenyl)methyl]morpholine;1-(4-tert-butylphenyl)-4-methylpiperazine;4-(4-tert-butylphenyl)morpholine;1-(4-tert-butylphenyl)piperazine;2-[4-(4-tert-butylphenyl)piperazin-1-yl]ethanol;1-(4-tert-butylphenyl)piperidine;1-(4-tert-butylphenyl)pyrazole;1-(5-tert-butyl-2-pyridinyl)piperazine
SMILESCC(C)(C)c1ccc(-n2cccn2)cc1.CC(C)(C)c1ccc(-n2ccnc2)cc1.CC(C)(C)c1ccc(N2CCCCC2)cc1.CC(C)(C)c1ccc(N2CCN(CCO)CC2)cc1.CC(C)(C)c1ccc(N2CCNCC2)cc1.CC(C)(C)c1ccc(N2CCNCC2)nc1.CC(C)(C)c1ccc(N2CCOCC2)cc1.CC(C)(C)c1ccc(OC2CCNCC2)cc1.CC(C)(C)c1cccc(CN2CCOCC2)c1.CN1CCN(Cc2ccc(C(C)(C)C)cc2)CC1.CN1CCN(c2ccc(C(C)(C)C)cc2)CC1
InChIInChI=1S/C16H26N2O.C16H26N2.C15H24N2.2C15H23NO.C15H23N.C14H22N2.C14H21NO.C13H21N3.2C13H16N2/c1-16(2,3)14-4-6-15(7-5-14)18-10-8-17(9-11-18)12-13-19;1-16(2,3)15-7-5-14(6-8-15)13-18-11-9-17(4)10-12-18;1-15(2,3)13-5-7-14(8-6-13)17-11-9-16(4)10-12-17;1-15(2,3)12-4-6-13(7-5-12)17-14-8-10-16-11-9-14;1-15(2,3)14-6-4-5-13(11-14)12-16-7-9-17-10-8-16;1-15(2,3)13-7-9-14(10-8-13)16-11-5-4-6-12-16;1-14(2,3)12-4-6-13(7-5-12)16-10-8-15-9-11-16;1-14(2,3)12-4-6-13(7-5-12)15-8-10-16-11-9-15;1-13(2,3)11-4-5-12(15-10-11)16-8-6-14-7-9-16;1-13(2,3)11-5-7-12(8-6-11)15-10-4-9-14-15;1-13(2,3)11-4-6-12(7-5-11)15-9-8-14-10-15/h4-7,19H,8-13H2,1-3H3;5-8H,9-13H2,1-4H3;5-8H,9-12H2,1-4H3;4-7,14,16H,8-11H2,1-3H3;4-6,11H,7-10,12H2,1-3H3;7-10H,4-6,11-12H2,1-3H3;4-7,15H,8-11H2,1-3H3;4-7H,8-11H2,1-3H3;4-5,10,14H,6-9H2,1-3H3;2*4-10H,1-3H3
InChIKeyJWEJIZLLRHAZDC-UHFFFAOYSA-N
MW2482.81 g/mol
LogP30.81
Rot. Bonds16

About 4-(4-tert-butylphenoxy)piperidine;1-(4-tert-butylphenyl)imidazole;1-[(4-tert-butylphenyl)methyl]-4-methylpiperazine;4-[(3-tert-butylphenyl)methyl]morpholine;1-(4-tert-butylphenyl)-4-methylpiperazine;4-(4-tert-butylphenyl)morpholine;1-(4-tert-butylphenyl)piperazine;2-[4-(4-tert-butylphenyl)piperazin-1-yl]ethanol;1-(4-tert-butylphenyl)piperidine;1-(4-tert-butylphenyl)pyrazole;1-(5-tert-butyl-2-pyridinyl)piperazine

4-(4-tert-butylphenoxy)piperidine;1-(4-tert-butylphenyl)imidazole;1-[(4-tert-butylphenyl)methyl]-4-methylpiperazine;4-[(3-tert-butylphenyl)methyl]morpholine;1-(4-tert-butylphenyl)-4-methylpiperazine;4-(4-tert-butylphenyl)morpholine;1-(4-tert-butylphenyl)piperazine;2-[4-(4-tert-butylphenyl)piperazin-1-yl]ethanol;1-(4-tert-butylphenyl)piperidine;1-(4-tert-butylphenyl)pyrazole;1-(5-tert-butyl-2-pyridinyl)piperazine (PubChem CID 159042031) has the molecular formula C159H241N19O4 and a molecular weight of 2482.81 g/mol. Its IUPAC name is 4-(4-tert-butylphenoxy)piperidine;1-(4-tert-butylphenyl)imidazole;1-[(4-tert-butylphenyl)methyl]-4-methylpiperazine;4-[(3-tert-butylphenyl)methyl]morpholine;1-(4-tert-butylphenyl)-4-methylpiperazine;4-(4-tert-butylphenyl)morpholine;1-(4-tert-butylphenyl)piperazine;2-[4-(4-tert-butylphenyl)piperazin-1-yl]ethanol;1-(4-tert-butylphenyl)piperidine;1-(4-tert-butylphenyl)pyrazole;1-(5-tert-butyl-2-pyridinyl)piperazine.

Molecular Properties

Compound Name4-(4-tert-butylphenoxy)piperidine;1-(4-tert-butylphenyl)imidazole;1-[(4-tert-butylphenyl)methyl]-4-methylpiperazine;4-[(3-tert-butylphenyl)methyl]morpholine;1-(4-tert-butylphenyl)-4-methylpiperazine;4-(4-tert-butylphenyl)morpholine;1-(4-tert-butylphenyl)piperazine;2-[4-(4-tert-butylphenyl)piperazin-1-yl]ethanol;1-(4-tert-butylphenyl)piperidine;1-(4-tert-butylphenyl)pyrazole;1-(5-tert-butyl-2-pyridinyl)piperazine
PubChem CID159042031
Molecular FormulaC159H241N19O4
Molecular Weight2482.81 g/mol
Exact Mass2480.92
IUPAC Name4-(4-tert-butylphenoxy)piperidine;1-(4-tert-butylphenyl)imidazole;1-[(4-tert-butylphenyl)methyl]-4-methylpiperazine;4-[(3-tert-butylphenyl)methyl]morpholine;1-(4-tert-butylphenyl)-4-methylpiperazine;4-(4-tert-butylphenyl)morpholine;1-(4-tert-butylphenyl)piperazine;2-[4-(4-tert-butylphenyl)piperazin-1-yl]ethanol;1-(4-tert-butylphenyl)piperidine;1-(4-tert-butylphenyl)pyrazole;1-(5-tert-butyl-2-pyridinyl)piperazine
SMILESCC(C)(C)c1ccc(-n2cccn2)cc1.CC(C)(C)c1ccc(-n2ccnc2)cc1.CC(C)(C)c1ccc(N2CCCCC2)cc1.CC(C)(C)c1ccc(N2CCN(CCO)CC2)cc1.CC(C)(C)c1ccc(N2CCNCC2)cc1.CC(C)(C)c1ccc(N2CCNCC2)nc1.CC(C)(C)c1ccc(N2CCOCC2)cc1.CC(C)(C)c1ccc(OC2CCNCC2)cc1.CC(C)(C)c1cccc(CN2CCOCC2)c1.CN1CCN(Cc2ccc(C(C)(C)C)cc2)CC1.CN1CCN(c2ccc(C(C)(C)C)cc2)CC1
InChIInChI=1S/C16H26N2O.C16H26N2.C15H24N2.2C15H23NO.C15H23N.C14H22N2.C14H21NO.C13H21N3.2C13H16N2/c1-16(2,3)14-4-6-15(7-5-14)18-10-8-17(9-11-18)12-13-19;1-16(2,3)15-7-5-14(6-8-15)13-18-11-9-17(4)10-12-18;1-15(2,3)13-5-7-14(8-6-13)17-11-9-16(4)10-12-17;1-15(2,3)12-4-6-13(7-5-12)17-14-8-10-16-11-9-14;1-15(2,3)14-6-4-5-13(11-14)12-16-7-9-17-10-8-16;1-15(2,3)13-7-9-14(10-8-13)16-11-5-4-6-12-16;1-14(2,3)12-4-6-13(7-5-12)16-10-8-15-9-11-16;1-14(2,3)12-4-6-13(7-5-12)15-8-10-16-11-9-15;1-13(2,3)11-4-5-12(15-10-11)16-8-6-14-7-9-16;1-13(2,3)11-5-7-12(8-6-11)15-10-4-9-14-15;1-13(2,3)11-4-6-12(7-5-11)15-9-8-14-10-15/h4-7,19H,8-13H2,1-3H3;5-8H,9-13H2,1-4H3;5-8H,9-12H2,1-4H3;4-7,14,16H,8-11H2,1-3H3;4-6,11H,7-10,12H2,1-3H3;7-10H,4-6,11-12H2,1-3H3;4-7,15H,8-11H2,1-3H3;4-7H,8-11H2,1-3H3;4-5,10,14H,6-9H2,1-3H3;2*4-10H,1-3H3
InChIKeyJWEJIZLLRHAZDC-UHFFFAOYSA-N
XLogP30.81
TPSA168.18 Ų
H-Bond Donors4
H-Bond Acceptors23
Rotatable Bonds16
Heavy Atoms182
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002482.81
LogP ≤ 530.81
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1023

Analyze 4-(4-tert-butylphenoxy)piperidine;1-(4-tert-butylphenyl)imidazole;1-[(4-tert-butylphenyl)methyl]-4-methylpiperazine;4-[(3-tert-butylphenyl)methyl]morpholine;1-(4-tert-butylphenyl)-4-methylpiperazine;4-(4-tert-butylphenyl)morpholine;1-(4-tert-butylphenyl)piperazine;2-[4-(4-tert-butylphenyl)piperazin-1-yl]ethanol;1-(4-tert-butylphenyl)piperidine;1-(4-tert-butylphenyl)pyrazole;1-(5-tert-butyl-2-pyridinyl)piperazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-(4-tert-butylphenoxy)piperidine;1-(4-tert-butylphenyl)imidazole;1-[(4-tert-butylphenyl)methyl]-4-methylpiperazine;4-[(3-tert-butylphenyl)methyl]morpholine;1-(4-tert-butylphenyl)-4-methylpiperazine;4-(4-tert-butylphenyl)morpholine;1-(4-tert-butylphenyl)piperazine;2-[4-(4-tert-butylphenyl)piperazin-1-yl]ethanol;1-(4-tert-butylphenyl)piperidine;1-(4-tert-butylphenyl)pyrazole;1-(5-tert-butyl-2-pyridinyl)piperazine?
The IUPAC name of 4-(4-tert-butylphenoxy)piperidine;1-(4-tert-butylphenyl)imidazole;1-[(4-tert-butylphenyl)methyl]-4-methylpiperazine;4-[(3-tert-butylphenyl)methyl]morpholine;1-(4-tert-butylphenyl)-4-methylpiperazine;4-(4-tert-butylphenyl)morpholine;1-(4-tert-butylphenyl)piperazine;2-[4-(4-tert-butylphenyl)piperazin-1-yl]ethanol;1-(4-tert-butylphenyl)piperidine;1-(4-tert-butylphenyl)pyrazole;1-(5-tert-butyl-2-pyridinyl)piperazine (CID 159042031) is 4-(4-tert-butylphenoxy)piperidine;1-(4-tert-butylphenyl)imidazole;1-[(4-tert-butylphenyl)methyl]-4-methylpiperazine;4-[(3-tert-butylphenyl)methyl]morpholine;1-(4-tert-butylphenyl)-4-methylpiperazine;4-(4-tert-butylphenyl)morpholine;1-(4-tert-butylphenyl)piperazine;2-[4-(4-tert-butylphenyl)piperazin-1-yl]ethanol;1-(4-tert-butylphenyl)piperidine;1-(4-tert-butylphenyl)pyrazole;1-(5-tert-butyl-2-pyridinyl)piperazine.
What is the SMILES notation for 4-(4-tert-butylphenoxy)piperidine;1-(4-tert-butylphenyl)imidazole;1-[(4-tert-butylphenyl)methyl]-4-methylpiperazine;4-[(3-tert-butylphenyl)methyl]morpholine;1-(4-tert-butylphenyl)-4-methylpiperazine;4-(4-tert-butylphenyl)morpholine;1-(4-tert-butylphenyl)piperazine;2-[4-(4-tert-butylphenyl)piperazin-1-yl]ethanol;1-(4-tert-butylphenyl)piperidine;1-(4-tert-butylphenyl)pyrazole;1-(5-tert-butyl-2-pyridinyl)piperazine?
The canonical SMILES for 4-(4-tert-butylphenoxy)piperidine;1-(4-tert-butylphenyl)imidazole;1-[(4-tert-butylphenyl)methyl]-4-methylpiperazine;4-[(3-tert-butylphenyl)methyl]morpholine;1-(4-tert-butylphenyl)-4-methylpiperazine;4-(4-tert-butylphenyl)morpholine;1-(4-tert-butylphenyl)piperazine;2-[4-(4-tert-butylphenyl)piperazin-1-yl]ethanol;1-(4-tert-butylphenyl)piperidine;1-(4-tert-butylphenyl)pyrazole;1-(5-tert-butyl-2-pyridinyl)piperazine is CC(C)(C)c1ccc(-n2cccn2)cc1.CC(C)(C)c1ccc(-n2ccnc2)cc1.CC(C)(C)c1ccc(N2CCCCC2)cc1.CC(C)(C)c1ccc(N2CCN(CCO)CC2)cc1.CC(C)(C)c1ccc(N2CCNCC2)cc1.CC(C)(C)c1ccc(N2CCNCC2)nc1.CC(C)(C)c1ccc(N2CCOCC2)cc1.CC(C)(C)c1ccc(OC2CCNCC2)cc1.CC(C)(C)c1cccc(CN2CCOCC2)c1.CN1CCN(Cc2ccc(C(C)(C)C)cc2)CC1.CN1CCN(c2ccc(C(C)(C)C)cc2)CC1.
What is the InChIKey of 4-(4-tert-butylphenoxy)piperidine;1-(4-tert-butylphenyl)imidazole;1-[(4-tert-butylphenyl)methyl]-4-methylpiperazine;4-[(3-tert-butylphenyl)methyl]morpholine;1-(4-tert-butylphenyl)-4-methylpiperazine;4-(4-tert-butylphenyl)morpholine;1-(4-tert-butylphenyl)piperazine;2-[4-(4-tert-butylphenyl)piperazin-1-yl]ethanol;1-(4-tert-butylphenyl)piperidine;1-(4-tert-butylphenyl)pyrazole;1-(5-tert-butyl-2-pyridinyl)piperazine?
The InChIKey is JWEJIZLLRHAZDC-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H26N2O.C16H26N2.C15H24N2.2C15H23NO.C15H23N.C14H22N2.C14H21NO.C13H21N3.2C13H16N2/c1-16(2,3)14-4-6-15(7-5-14)18-10-8-17(9-11-18)12-13-19;1-16(2,3)15-7-5-14(6-8-15)13-18-11-9-17(4)10-12-18;1-15(2,3)13-5-7-14(8-6-13)17-11-9-16(4)10-12-17;1-15(2,3)12-4-6-13(7-5-12)17-14-8-10-16-11-9-14;1-15(2,3)14-6-4-5-13(11-14)12-16-7-9-17-10-8-16;1-15(2,3)13-7-9-14(10-8-13)16-11-5-4-6-12-16;1-14(2,3)12-4-6-13(7-5-12)16-10-8-15-9-11-16;1-14(2,3)12-4-6-13(7-5-12)15-8-10-16-11-9-15;1-13(2,3)11-4-5-12(15-10-11)16-8-6-14-7-9-16;1-13(2,3)11-5-7-12(8-6-11)15-10-4-9-14-15;1-13(2,3)11-4-6-12(7-5-11)15-9-8-14-10-15/h4-7,19H,8-13H2,1-3H3;5-8H,9-13H2,1-4H3;5-8H,9-12H2,1-4H3;4-7,14,16H,8-11H2,1-3H3;4-6,11H,7-10,12H2,1-3H3;7-10H,4-6,11-12H2,1-3H3;4-7,15H,8-11H2,1-3H3;4-7H,8-11H2,1-3H3;4-5,10,14H,6-9H2,1-3H3;2*4-10H,1-3H3.
What are the key properties of 4-(4-tert-butylphenoxy)piperidine;1-(4-tert-butylphenyl)imidazole;1-[(4-tert-butylphenyl)methyl]-4-methylpiperazine;4-[(3-tert-butylphenyl)methyl]morpholine;1-(4-tert-butylphenyl)-4-methylpiperazine;4-(4-tert-butylphenyl)morpholine;1-(4-tert-butylphenyl)piperazine;2-[4-(4-tert-butylphenyl)piperazin-1-yl]ethanol;1-(4-tert-butylphenyl)piperidine;1-(4-tert-butylphenyl)pyrazole;1-(5-tert-butyl-2-pyridinyl)piperazine?
4-(4-tert-butylphenoxy)piperidine;1-(4-tert-butylphenyl)imidazole;1-[(4-tert-butylphenyl)methyl]-4-methylpiperazine;4-[(3-tert-butylphenyl)methyl]morpholine;1-(4-tert-butylphenyl)-4-methylpiperazine;4-(4-tert-butylphenyl)morpholine;1-(4-tert-butylphenyl)piperazine;2-[4-(4-tert-butylphenyl)piperazin-1-yl]ethanol;1-(4-tert-butylphenyl)piperidine;1-(4-tert-butylphenyl)pyrazole;1-(5-tert-butyl-2-pyridinyl)piperazine has a molecular weight of 2482.81 g/mol, XLogP of 30.81, 16 rotatable bonds, 4 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(4-tert-butylphenoxy)piperidine;1-(4-tert-butylphenyl)imidazole;1-[(4-tert-butylphenyl)methyl]-4-methylpiperazine;4-[(3-tert-butylphenyl)methyl]morpholine;1-(4-tert-butylphenyl)-4-methylpiperazine;4-(4-tert-butylphenyl)morpholine;1-(4-tert-butylphenyl)piperazine;2-[4-(4-tert-butylphenyl)piperazin-1-yl]ethanol;1-(4-tert-butylphenyl)piperidine;1-(4-tert-butylphenyl)pyrazole;1-(5-tert-butyl-2-pyridinyl)piperazine is sourced from PubChem (CID 159042031), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).